Your Followed Topics

Top 3 stamford, usa News Today

#1
JOSH ALLEN RANKS NO. 1; JOE BURROW, LAMAR JACKSON, PATRICK MAHOMES, AND MATTHEW STAFFORD RANK 2-5 IN CHRIS SIMMS’ QUARTERBACK COUNTDOWN, NOW ON “CHRIS SIMMS UNBUTTONED” AND “PRO FOOTBALL TALK”
#1 out of 3
sports48m ago

JOSH ALLEN RANKS NO. 1; JOE BURROW, LAMAR JACKSON, PATRICK MAHOMES, AND MATTHEW STAFFORD RANK 2-5 IN CHRIS SIMMS’ QUARTERBACK COUNTDOWN, NOW ON “CHRIS SIMMS UNBUTTONED” AND “PRO FOOTBALL TALK”

  • Josh Allen is named the top quarterback in the NFL by Chris Simms in the countdown.
  • The ranking places Burrow, Jackson, Mahomes, and Stafford in spots 2–5, shaping the top tier for 2026.
  • Simms notes Allen’s offensive impact and calling the Bills’ offense heavily centered around him.
  • The article includes detailed notes on Burrow’s pocket efficiency and Burrow’s ranking rationale.
  • Lamar Jackson is described as one of the greatest quarterbacks by Simms in the countdown.
  • Patrick Mahomes is noted for outstanding on-field play despite potential injury considerations.
  • Matthew Stafford is highlighted as a potential Hall of Fame-level quarterback if he adds another title.
  • The piece notes the countdown is available on Chris Simms Unbuttoned and Pro Football Talk.
  • The countdown includes references to Caleb Williams and future prospects within the same feature stream.
  • The article frames the rankings as part of a weekly series with analyses and breakdowns.
Vote 0
0
#2
California man stole $1.2M from New Canaan real estate firm, warrant says
#2 out of 3
crime1d ago

California man stole $1.2M from New Canaan real estate firm, warrant says

  • A California man, Zachary Lee Baker, is charged with first-degree larceny, identity theft and computer crime in connection with a $1.27 million real estate fraud case in New Canaan.
  • Investigators say the funds were diverted via spoofed emails and altered wire instructions, redirecting about $1.27 million from BedRock’s account to Baker’s Citibank account.
  • Surveillance footage linked Baker to the fraud, showing him at a Citibank in Los Angeles on multiple February 2024 days.
  • BedRock Real Estate reported the loss after discovering $1,272,500 diverted from a completion guaranty, prompting the investigation.
  • The case also involves a related fraud in Buckingham Township, Pennsylvania, and Los Angeles forgery charges.
  • Baker remains jailed on a $100,000 bond with a plea hearing scheduled for July 29, 2026.
  • The incident highlights how compromised email accounts can facilitate large-scale corporate fraud.
  • The investigation connected bank and surveillance records to Baker, including a driver’s license image and deposit records.
  • BedRock initiated an internal forensic analysis after discovering the fraud around February 2024.
  • Baker’s case has a regional footprint, with investigations and charges spanning Connecticut, Pennsylvania and California.
Vote 0
0
#3
Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas
#3 out of 3
business1d ago

Eli Lilly's top dealmaker says don't be surprised to see more M&A that pushes Lilly into new areas

  • Lilly is using GLP-1 windfall strength to fund a broader dealmaking strategy across multiple disease areas.
  • Jacob S. Van Naarden, Lilly’s EVP and head of oncology, now also leads corporate development to sharpen dealmaking.
  • Lilly plans to spend up to $25 billion on up to eight acquisitions this year.
  • The company’s market capitalization is around $1 trillion, up from $190 billion in 2021.
  • Lilly is diversifying beyond its traditional early bets to include broader opportunities across several therapeutic areas.
  • Lilly’s 2026 deals include a $1.9 billion collaboration with Ascidian Therapeutics for kidney diseases.
  • Lilly aims to redeploy capital across oncology, neuroscience, cardiometabolic health and immunology.
  • Lilly’s leadership says the size of deals hinges on science quality and patient impact, not arbitrary limits.
  • Lilly joined the trillion-dollar club as it grows into the world’s largest pharmaceutical company.
  • The strategy shift reflects Lilly’s transition from early bets to larger, more certain investments.
Vote 0
0

Explore Your Interests

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
or
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Advertisement

Advertisement